Treatment of patients with non-Hodgkin's lymphoma with bone marrow lesions by anti-CD20 antibodies

摘要

This invention relates to methods of reducing bone marrow involvement in B cell lymphoma patients prior to radioimmunotherapy by administering monoclonal antibodies which target cancerous B cells.